Nancy Hemphill is a Senior Editorial Director at Healio. With a focus on medicine and healthcare, she specializes in topics such as surgery, digital health, and telehealth, while also overseeing optometry and ophthalmology content channels. Hemphill has been featured in the Environmental Post Ledger and has received numerous awards for her contributions to medical publishing.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Nancy Hemphill's coverage spans healthcare, pharmaceuticals, and scientific topics related to eye care, visual function, and ocular health. Her articles often cite data and press releases.
To effectively pitch to Nancy Hemphill, consider providing access to new research findings or exclusive interviews with experts in the field of optometry or ophthalmology. Given her focus on scientific themes like visual function and specific eye conditions such as keratoconus and dry eye disease, pitches should offer insights into cutting-edge treatments or developments in these areas.
Since Nancy's geographic focus is not specified but she covers a wide range of topics within the healthcare sector without a clear regional emphasis, it would be beneficial for sources pitching stories related to medical advancements or studies in any location globally.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Eamon N. Dreisbach
KIAWAH ISLAND, S.C. — Several treatments are available across the landscape of proliferative diabetic retinopathy, each with their own considerations, according to a speaker. At Kiawah Eye and Retina, David Baxley, MD, a resident at Medical University of South Carolina’s Storm Eye Institute, offered an overview of available therapies.
By: Eamon N. Dreisbach, Nancy Hemphill, Steve Charles
KIAWAH ISLAND, S.C. — Cataract surgery should be performed midway between any anti-VEGF injections a patient may be receiving, Steve Charles, MD, said at Kiawah Eye and Retina.
By: Nancy Hemphill, Justin Cooper
Some repeated low-level red light therapy devices for myopia control may not meet safety standards for lasers and ophthalmic lights, according to data published in JAMA Ophthalmology
By: Justin Cooper
PHOENIX — Most patients who used Xiidra eye drops had a “clinically meaningful” reduction in eye dryness by the 84th day of treatment, with some responding within 2 weeks, according to data presented at Optometry’s Meeting.“Dry eye is a multifactorial disease, and there are a lot of things that contribute to its pathogenesis, meaning that it can be sometimes
By: Nancy Hemphill, Gloria B. Chiu
See all articles from Mastering Keratoconus Epioxa obtained FDA approval in October 2025, which makes it the first and only FDA-approved
By: Nancy Hemphill
Editor's note: This is a developing news story. Please check back soon for updates.
Key takeaways: Herbert E. Kaufman, MD, is renowned for his vision-saving innovations, including the discovery of idoxuridine.
By: Lauren A. Perry, Nancy Hemphill
Eschenbach Optik of America has launched the Magno Digital video magnifier, aimed to assist with activities of daily life among patients with
By: Christine Klimanskis, Nancy Hemphill
PHOENIX — While it is uncommon for a patient to lose consciousness in an eye care practice, clinicians and their staff should know the warning signs and how to prevent injury, according to a speaker at Optometry's Meeting.
By: Walker L. Shaffer, Nancy Hemphill
In my previous article , I discussed practical functional tests and systemic biomarkers that can be used to assess retinal reserve.
